Abstract
Setmelanotide (IMCIVREE (TM), Rhythm Pharmaceuticals) is a melanocortin-4 (MC4) receptor agonist developed for the treatment of obesity arising from p......
小提示:本篇文献需要登录阅读全文,点击跳转登录